At a glance
- Originator Sankyo
- Class Antibacterials
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 18 May 2001 Discontinued-Preclinical for Bacterial infections in Japan (Unknown route)
- 05 May 1998 New profile
- 05 May 1998 Preclinical development for Bacterial infections in Japan (Unknown route)